Literature DB >> 2976544

Antiproliferative effect of Hu-interferon-gamma in 674V and J82 bladder carcinoma cell lines.

G Jakse1, C Marth, J Zechner, G Daxenbichler.   

Abstract

Hu-IFN-gamma was evaluated in regard to the antiproliferative effect on J82 and 647V bladder cancer cell lines. In addition, the IFN-receptors were determined. There was a significant growth inhibition of J82 as well as 647V at low dose Hu-IFN-g (1 U/ml). The growth inhibition was significantly higher in 647V than in J82. The binding assay for 125J-Hu-IFN-g revealed 870 and 3,000 binding sites for 647V and J82, respectively, indicating that the antiproliferative effect of Hu-IFN-g may not depend on the absolute amount of IFN-receptors, in the two cell lines tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976544     DOI: 10.1007/bf00280019

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  14 in total

1.  Binding of human gamma-interferon to human epidermal tumor cells with different susceptibilities.

Authors:  S Nagao; K Sato; Y Osada
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

2.  Biological effects of gamma-interferon on human tumor cells: quantity and affinity of cell membrane receptors for gamma-IFN in relation to growth inhibition and induction of HLA-DR expression.

Authors:  U Ucer; H Bartsch; P Scheurich; K Pfizenmaier
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

3.  Effect of human recombinant alpha-2- and gamma-interferon on the growth of human cell lines from solid tumors and hematologic malignancies.

Authors:  H Denz; M Lechleitner; C Marth; G Daxenbichler; G Gastl; H Braunsteiner
Journal:  J Interferon Res       Date:  1985

4.  The synergistic anti-proliferative effect of gamma-interferon and human lymphotoxin.

Authors:  S H Lee; B B Aggarwal; E Rinderknecht; F Assisi; H Chiu
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

5.  Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice.

Authors:  J E Talmadge; H R Tribble; R W Pennington; H Phillips; R H Wiltrout
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

6.  Cytolytic activity of interferon-gamma and its synergism with 5-fluorouracil.

Authors:  J Le; Y K Yip; J Vilcek
Journal:  Int J Cancer       Date:  1984-10-15       Impact factor: 7.396

7.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

8.  Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.

Authors:  G Gastl; C Marth; E Leiter; C Gattringer; I Mayer; G Daxenbichler; R Flener; C Huber
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

9.  Modulation of human interferon-alpha receptor expression by human interferon-gamma.

Authors:  G E Hannigan; E N Fish; B R Williams
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

10.  Human interferon-gamma is internalized and degraded by cultured fibroblasts.

Authors:  P Anderson; Y K Yip; J Vilcek
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

View more
  2 in total

1.  Expression of interferon-gamma receptors on bladder cancer cells: does it correlate with biological response?

Authors:  S J Hawkyard; A M Jackson; R A Hawkins; K James; J F Smyth; G D Chisholm
Journal:  Urol Res       Date:  1992

2.  Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro.

Authors:  K Pryor; P Stricker; P Russell; D Golovsky; R Penny
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.